amiodarone has been researched along with Mucositis, Oral in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Neve, W | 1 |
| Fortan, L | 1 |
| Storme, G | 1 |
| Demange, L | 1 |
| Marechal, F | 1 |
| Nguyen, TD | 1 |
2 other studies available for amiodarone and Mucositis, Oral
| Article | Year |
|---|---|
Increased acute mucosal and cutaneous radiation toxicity in two patients taking amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Carcinoma, Squamous Cell; Ear Neoplasms; Humans; Male; Mouth Mu | 1992 |
Could amiodarone increase acute cutaneous and mucosal toxicity of radiotherapy?
Topics: Aged; Amiodarone; Humans; Male; Mouth Mucosa; Radiotherapy; Skin Diseases; Stomatitis | 1987 |